PLEK
Basic information
Region (hg38): 2:68365282-68397453
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (38 variants)
- not_provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLEK gene is commonly pathogenic or not. These statistics are base on transcript: NM_000002664.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 38 | 39 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 38 | 0 | 1 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PLEK | protein_coding | protein_coding | ENST00000234313 | 9 | 32281 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00107 | 0.989 | 125717 | 0 | 20 | 125737 | 0.0000795 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.211 | 178 | 186 | 0.956 | 0.00000905 | 2326 |
| Missense in Polyphen | 54 | 64.033 | 0.84332 | 835 | ||
| Synonymous | -0.203 | 69 | 66.9 | 1.03 | 0.00000330 | 615 |
| Loss of Function | 2.27 | 8 | 18.6 | 0.431 | 8.50e-7 | 236 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000579 | 0.0000579 |
| Ashkenazi Jewish | 0.0000995 | 0.0000992 |
| East Asian | 0.000273 | 0.000272 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000106 | 0.000106 |
| Middle Eastern | 0.000273 | 0.000272 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Major protein kinase C substrate of platelets.;
- Pathway
- Serotonin and anxiety;Serotonin and anxiety-related events;TYROBP Causal Network;Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Hemostasis
(Consensus)
Recessive Scores
- pRec
- 0.352
Intolerance Scores
- loftool
- 0.453
- rvis_EVS
- 0.55
- rvis_percentile_EVS
- 81.48
Haploinsufficiency Scores
- pHI
- 0.348
- hipred
- Y
- hipred_score
- 0.513
- ghis
- 0.504
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.108
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | Medium | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Plek
- Phenotype
- hematopoietic system phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- hematopoietic progenitor cell differentiation;platelet degranulation;regulation of transcription by RNA polymerase II;vesicle docking involved in exocytosis;integrin-mediated signaling pathway;positive regulation of platelet activation;negative regulation of inositol phosphate biosynthetic process;positive regulation of inositol-polyphosphate 5-phosphatase activity;cell projection organization;positive regulation of actin filament depolymerization;phospholipase C-inhibiting G protein-coupled receptor signaling pathway;cortical actin cytoskeleton organization;ruffle organization;actin cytoskeleton reorganization;positive regulation of actin filament bundle assembly;positive regulation of integrin activation;negative regulation of G protein-coupled receptor signaling pathway;phosphatidylinositol metabolic process;negative regulation of calcium-mediated signaling;regulation of cell diameter;thrombin-activated receptor signaling pathway;platelet aggregation;protein kinase C signaling;protein secretion by platelet
- Cellular component
- extracellular region;cytoplasm;cytosol;plasma membrane;membrane;ruffle membrane
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;protein kinase C binding;protein binding;protein homodimerization activity;phosphatidylinositol-3,4-bisphosphate binding